Variant report
Variant | esv2757108 |
---|---|
Chromosome Location | chr5:17398090-17804346 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3173)
- CpG islands (count:2198)
- Chromatin interactive region (count:50)
- LncRNA region (count:53)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr5:17526839-17526866 | K562 | blood: | n/a | n/a |
2 | ARID3A | chr5:17398657-17398856 | K562 | blood: | n/a | n/a |
3 | ARID3A | chr5:17400080-17400209 | K562 | blood: | n/a | n/a |
4 | ARID3A | chr5:17517830-17517852 | K562 | blood: | n/a | n/a |
5 | ATF1 | chr5:17400709-17401396 | K562 | blood: | n/a | n/a |
6 | ATF1 | chr5:17517811-17517870 | K562 | blood: | n/a | n/a |
7 | ATF1 | chr5:17398236-17399036 | K562 | blood: | n/a | n/a |
8 | ATF1 | chr5:17400131-17400411 | K562 | blood: | n/a | n/a |
9 | ATF1 | chr5:17413435-17413764 | K562 | blood: | n/a | n/a |
10 | ATF1 | chr5:17492224-17492379 | K562 | blood: | n/a | n/a |
11 | ATF1 | chr5:17415654-17415786 | K562 | blood: | n/a | n/a |
12 | ATF2 | chr5:17425402-17425976 | GM12878 | blood: | n/a | n/a |
13 | ATF2 | chr5:17425371-17425899 | GM12878 | blood: | n/a | n/a |
14 | ATF2 | chr5:17401891-17402229 | H1-hESC | embryonic stem cell: | n/a | n/a |
15 | ATF2 | chr5:17426396-17426854 | GM12878 | blood: | n/a | n/a |
16 | ATF3 | chr5:17517759-17517894 | K562 | blood: | n/a | n/a |
17 | ATF3 | chr5:17443879-17444164 | K562 | blood: | n/a | n/a |
18 | BACH1 | chr5:17434247-17434354 | K562 | blood: | n/a | n/a |
19 | BACH1 | chr5:17413521-17413685 | K562 | blood: | n/a | chr5:17413586-17413600 |
20 | BACH1 | chr5:17400938-17402146 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | BACH1 | chr5:17680992-17681026 | K562 | blood: | n/a | n/a |
22 | BACH1 | chr5:17526845-17526876 | K562 | blood: | n/a | n/a |
23 | BACH1 | chr5:17415528-17415532 | H1-hESC | embryonic stem cell: | n/a | n/a |
24 | BATF | chr5:17588662-17591030 | GM12878 | blood: | n/a | n/a |
25 | BATF | chr5:17520861-17521352 | GM12878 | blood: | n/a | n/a |
26 | BATF | chr5:17591806-17592083 | GM12878 | blood: | n/a | n/a |
27 | BATF | chr5:17581436-17582365 | GM12878 | blood: | n/a | n/a |
28 | BATF | chr5:17580902-17581080 | GM12878 | blood: | n/a | n/a |
29 | BATF | chr5:17586589-17586869 | GM12878 | blood: | n/a | n/a |
30 | BATF | chr5:17586894-17587691 | GM12878 | blood: | n/a | n/a |
31 | BATF | chr5:17632271-17632495 | GM12878 | blood: | n/a | n/a |
32 | BATF | chr5:17599390-17599669 | GM12878 | blood: | n/a | n/a |
33 | BATF | chr5:17588369-17588646 | GM12878 | blood: | n/a | n/a |
34 | BATF | chr5:17521816-17524282 | GM12878 | blood: | n/a | n/a |
35 | BATF | chr5:17499625-17499833 | GM12878 | blood: | n/a | n/a |
36 | BATF | chr5:17583170-17583447 | GM12878 | blood: | n/a | n/a |
37 | BATF | chr5:17518387-17521181 | GM12878 | blood: | n/a | n/a |
38 | BATF | chr5:17581115-17581413 | GM12878 | blood: | n/a | n/a |
39 | BATF | chr5:17524307-17524569 | GM12878 | blood: | n/a | n/a |
40 | BATF | chr5:17599128-17599665 | GM12878 | blood: | n/a | n/a |
41 | BATF | chr5:17521821-17524301 | GM12878 | blood: | n/a | n/a |
42 | BATF | chr5:17633787-17633984 | GM12878 | blood: | n/a | n/a |
43 | BATF | chr5:17588377-17588634 | GM12878 | blood: | n/a | n/a |
44 | BATF | chr5:17591814-17594470 | GM12878 | blood: | n/a | n/a |
45 | BATF | chr5:17583178-17585829 | GM12878 | blood: | n/a | n/a |
46 | BATF | chr5:17525250-17527716 | GM12878 | blood: | n/a | n/a |
47 | BATF | chr5:17528689-17530680 | GM12878 | blood: | n/a | n/a |
48 | BATF | chr5:17631481-17631659 | GM12878 | blood: | n/a | n/a |
49 | BATF | chr5:17524295-17524851 | GM12878 | blood: | n/a | n/a |
50 | BATF | chr5:17581121-17581401 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:17632536-17632586 | SK-N-SH | brain: | n/a |
2 | chr5:17528991-17529041 | PrEC | prostate: | n/a |
3 | chr5:17632536-17632586 | SK-N-SH | brain: | n/a |
4 | chr5:17528991-17529041 | PrEC | prostate: | n/a |
5 | chr5:17670442-17670492 | Hela-S3 | cervix: | n/a |
6 | chr5:17802512-17802562 | ovcar-3 | ovarian: | n/a |
7 | chr5:17632536-17632586 | HL-60 | blood: | n/a |
8 | chr5:17631696-17631746 | SK-N-MC | brain: | n/a |
9 | chr5:17444401-17444451 | PrEC | prostate: | n/a |
10 | chr5:17400323-17400373 | HIPEpiC | eye: | n/a |
11 | chr5:17664567-17664617 | HCPEpiC | choroid plexus: | n/a |
12 | chr5:17495781-17495831 | HPAEpiC | pulmonary alveolar: | n/a |
13 | chr5:17495781-17495831 | HRPEpiC | eye: | n/a |
14 | chr5:17414184-17414234 | HRPEpiC | eye: | n/a |
15 | chr5:17604867-17604917 | GM12892 | blood: | n/a |
16 | chr5:17631696-17631746 | NHDF-neo | bronchial: | n/a |
17 | chr5:17517201-17517251 | U87 | brain: | n/a |
18 | chr5:17656637-17656687 | NHBE | bronchial: | n/a |
19 | chr5:17528991-17529041 | HUVEC | blood vessel: | n/a |
20 | chr5:17522582-17522632 | Caco-2 | colon: | n/a |
21 | chr5:17632557-17632607 | PFSK-1 | brain: | n/a |
22 | chr5:17491941-17491991 | Jurkat | blood: | n/a |
23 | chr5:17595441-17595491 | SKMC | muscle: | n/a |
24 | chr5:17654594-17654644 | HCPEpiC | choroid plexus: | n/a |
25 | chr5:17400323-17400373 | HL-60 | blood: | n/a |
26 | chr5:17488879-17488929 | HEEpiC | esophagus: | n/a |
27 | chr5:17491941-17491991 | HRCEpiC | kidney: | n/a |
28 | chr5:17491941-17491991 | HCF | heart: | n/a |
29 | chr5:17528991-17529041 | PFSK-1 | brain: | n/a |
30 | chr5:17632557-17632607 | BE2_C | brain: | n/a |
31 | chr5:17580826-17580876 | AG09319 | gingival: | n/a |
32 | chr5:17488879-17488929 | HRPEpiC | eye: | n/a |
33 | chr5:17632536-17632586 | Jurkat | blood: | n/a |
34 | chr5:17485435-17485485 | NHDF-neo | bronchial: | n/a |
35 | chr5:17401890-17401940 | AG09319 | gingival: | n/a |
36 | chr5:17491604-17491654 | HCT-116 | colon: | n/a |
37 | chr5:17634462-17634512 | GM12878 | blood: | n/a |
38 | chr5:17670475-17670525 | MCF-7 | breast: | n/a |
39 | chr5:17604867-17604917 | PFSK-1 | brain: | n/a |
40 | chr5:17490778-17490828 | HepG2 | liver: | n/a |
41 | chr5:17632557-17632607 | U87 | brain: | n/a |
42 | chr5:17414184-17414234 | HAEpiC | amniotic membrane: | n/a |
43 | chr5:17517201-17517251 | HEEpiC | esophagus: | n/a |
44 | chr5:17400323-17400373 | HepG2 | liver: | n/a |
45 | chr5:17670475-17670525 | HCF | heart: | n/a |
46 | chr5:17604867-17604917 | HIPEpiC | eye: | n/a |
47 | chr5:17670442-17670492 | HIPEpiC | eye: | n/a |
48 | chr5:17632043-17632093 | HRE | kidney: | n/a |
49 | chr5:17401890-17401940 | ECC-1 | luminal epithelium: | n/a |
50 | chr5:17517201-17517251 | AG09309 | skin: | n/a |
(count:50 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:17702899..17705763-chr5:17710587..17714118,3 | MCF-7 | breast: | |
2 | chr5:17719378..17721402-chr5:17724190..17726007,2 | MCF-7 | breast: | |
3 | chr5:17446833..17449235-chr5:17452939..17454886,2 | MCF-7 | breast: | |
4 | chr5:17393977..17396441-chr5:17404895..17406641,2 | MCF-7 | breast: | |
5 | chr5:17428609..17430151-chr5:17432039..17433769,2 | MCF-7 | breast: | |
6 | chr5:17737382..17739045-chr5:17741320..17743486,2 | K562 | blood: | |
7 | chr5:17217433..17219821-chr5:17690448..17693197,3 | MCF-7 | breast: | |
8 | chr5:17482145..17483996-chr5:17485919..17488626,2 | MCF-7 | breast: | |
9 | chr5:17444658..17447223-chr5:17452681..17454773,2 | MCF-7 | breast: | |
10 | chr5:17635261..17638059-chr5:17641232..17643907,2 | MCF-7 | breast: | |
11 | chr5:17216329..17216875-chr5:17413138..17413983,2 | MCF-7 | breast: | |
12 | chr5:17448288..17450803-chr5:17469886..17472287,2 | K562 | blood: | |
13 | chr5:17445129..17446748-chr5:17447906..17450127,2 | MCF-7 | breast: | |
14 | chr5:17422805..17424378-chr5:17424436..17427431,2 | MCF-7 | breast: | |
15 | chr5:17801716..17804540-chr5:17805229..17807105,2 | K562 | blood: | |
16 | chr5:17463203..17464706-chr5:17470171..17472480,2 | MCF-7 | breast: | |
17 | chr5:17491440..17494172-chr5:17495062..17497549,2 | MCF-7 | breast: | |
18 | chr5:17399274..17401360-chr5:17404322..17406946,2 | MCF-7 | breast: | |
19 | chr5:17216395..17218536-chr5:17655025..17657774,2 | MCF-7 | breast: | |
20 | chr5:17445953..17448807-chr5:17455324..17457089,2 | K562 | blood: | |
21 | chr5:17788405..17790978-chr5:17794011..17796191,2 | MCF-7 | breast: | |
22 | chr5:17463203..17464706-chr5:17470171..17472480,2 | MCF-7 | breast: | |
23 | chr5:17632983..17635813-chr5:17637711..17640599,2 | K562 | blood: | |
24 | chr5:17391442..17394133-chr5:17400985..17402513,2 | MCF-7 | breast: | |
25 | chr5:17365516..17367373-chr5:17399549..17401386,2 | K562 | blood: | |
26 | chr5:17491440..17494172-chr5:17495062..17497549,2 | MCF-7 | breast: | |
27 | chr5:17444658..17447223-chr5:17452681..17454773,2 | MCF-7 | breast: | |
28 | chr5:17448288..17450803-chr5:17469886..17472287,2 | K562 | blood: | |
29 | chr5:17798564..17800322-chr5:17802790..17805535,2 | K562 | blood: | |
30 | chr5:17719378..17721402-chr5:17724190..17726007,2 | MCF-7 | breast: | |
31 | chr5:17422805..17424378-chr5:17424436..17427431,2 | MCF-7 | breast: | |
32 | chr5:17737382..17739045-chr5:17741320..17743486,2 | K562 | blood: | |
33 | chr5:17693367..17696364-chr5:17702400..17704641,2 | MCF-7 | breast: | |
34 | chr5:17428609..17430151-chr5:17432039..17433769,2 | MCF-7 | breast: | |
35 | chr5:17702899..17705763-chr5:17710587..17714118,3 | MCF-7 | breast: | |
36 | chr5:17401084..17403430-chr5:17409103..17412028,2 | K562 | blood: | |
37 | chr5:17216689..17219268-chr5:17450632..17453590,2 | MCF-7 | breast: | |
38 | chr5:17644806..17646667-chr5:17648582..17651312,2 | MCF-7 | breast: | |
39 | chr5:17788405..17790978-chr5:17794011..17796191,2 | MCF-7 | breast: | |
40 | chr5:17445953..17448807-chr5:17455324..17457089,2 | K562 | blood: | |
41 | chr5:17413771..17415306-chr5:17416901..17419149,2 | MCF-7 | breast: | |
42 | chr5:17401084..17403430-chr5:17409103..17412028,2 | K562 | blood: | |
43 | chr5:17445129..17446748-chr5:17447906..17450127,2 | MCF-7 | breast: | |
44 | chr5:17798564..17800322-chr5:17802790..17805535,2 | K562 | blood: | |
45 | chr5:17399274..17401360-chr5:17404322..17406946,2 | MCF-7 | breast: | |
46 | chr5:17446833..17449235-chr5:17452939..17454886,2 | MCF-7 | breast: | |
47 | chr5:17223492..17225946-chr5:17474747..17476783,2 | MCF-7 | breast: | |
48 | chr5:17693367..17696364-chr5:17702400..17704641,2 | MCF-7 | breast: | |
49 | chr5:17215792..17218205-chr5:17402099..17403683,2 | MCF-7 | breast: | |
50 | chr5:17413771..17415306-chr5:17416901..17419149,2 | MCF-7 | breast: |
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-BASP1-7 | chr5:17684693-17684796 | NONHSAT100665 |
2 | lnc-BASP1-3 | chr5:17441577-17441809 | NONHSAT100641 |
3 | lnc-BASP1-4 | chr5:17485639-17485937 | XLOC_004309 |
4 | lnc-BASP1-4 | chr5:17444119-17444343 | XLOC_004309 |
5 | lnc-BASP1-3 | chr5:17440223-17440293 | XLOC_004308 |
6 | lnc-BASP1-3 | chr5:17441578-17442654 | XLOC_004308 |
7 | lnc-BASP1-4 | chr5:17444119-17444343 | XLOC_004309 |
8 | lnc-BASP1-4 | chr5:17483931-17484068 | XLOC_004309 |
9 | lnc-BASP1-7 | chr5:17769003-17769093 | NONHSAT100665 |
10 | lnc-BASP1-3 | chr5:17404535-17404838 | XLOC_004308 |
11 | lnc-BASP1-4 | chr5:17483841-17484055 | XLOC_004309 |
12 | lnc-MYO10-19 | chr5:17654482-17654752 | NONHSAT100661 |
13 | lnc-BASP1-3 | chr5:17437289-17437322 | XLOC_004308 |
14 | lnc-BASP1-3 | chr5:17404128-17404197 | XLOC_004308 |
15 | lnc-BASP1-3 | chr5:17404213-17404838 | XLOC_004308 |
16 | lnc-BASP1-3 | chr5:17441578-17441787 | XLOC_004308 |
17 | lnc-BASP1-3 | chr5:17441578-17441826 | NONHSAT100634 |
18 | lnc-BASP1-4 | chr5:17445736-17446039 | XLOC_004309 |
19 | lnc-BASP1-3 | chr5:17404217-17404429 | XLOC_004308 |
20 | lnc-BASP1-3 | chr5:17430038-17430385 | NONHSAT100631 |
21 | lnc-BASP1-11 | chr5:17456970-17457429 | l_2885_chr5:17456969-17494846_brain |
22 | lnc-BASP1-11 | chr5:17494578-17494846 | l_2885_chr5:17456969-17494846_brain |
23 | lnc-BASP1-3 | chr5:17404098-17404197 | NONHSAT100634 |
24 | lnc-MYO10-8 | chr5:17437952-17438549 | ucscGeneNc_uc003jga_2 |
25 | lnc-BASP1-7 | chr5:17684693-17684796 | ENSG00000249937 |
26 | lnc-BASP1-3 | chr5:17441578-17441787 | XLOC_004308 |
27 | lnc-MYO10-8 | chr5:17432016-17433619 | ucscGeneNc_uc003jga_2 |
28 | lnc-BASP1-4 | chr5:17477724-17477865 | XLOC_004309 |
29 | lnc-BASP1-3 | chr5:17404040-17404197 | XLOC_004308 |
30 | lnc-BASP1-3 | chr5:17441578-17441787 | XLOC_004308 |
31 | lnc-BASP1-3 | chr5:17412000-17412207 | NONHSAT100631 |
32 | lnc-BASP1-3 | chr5:17404535-17404701 | XLOC_004308 |
33 | lnc-BASP1-3 | chr5:17441578-17441846 | XLOC_004308 |
34 | lnc-BASP1-3 | chr5:17441578-17442297 | XLOC_004308 |
35 | lnc-MYO10-17 | chr5:17643071-17643337 | NONHSAT100659 |
36 | lnc-BASP1-3 | chr5:17404535-17404838 | XLOC_004308 |
37 | lnc-BASP1-3 | chr5:17430053-17430082 | XLOC_004308 |
38 | lnc-BASP1-3 | chr5:17404667-17404840 | XLOC_004308 |
39 | lnc-BASP1-11 | chr5:17457474-17457838 | l_2885_chr5:17456969-17494846_brain |
40 | lnc-MYO10-8 | chr5:17440311-17440416 | ucscGeneNc_uc003jga_2 |
41 | lnc-BASP1-3 | chr5:17404005-17404178 | XLOC_004308 |
42 | lnc-BASP1-3 | chr5:17412001-17412207 | XLOC_004308 |
43 | lnc-BASP1-3 | chr5:17436845-17437322 | NONHSAT100641 |
44 | lnc-BASP1-3 | chr5:17404039-17404474 | NONHSAT100631 |
45 | lnc-BASP1-3 | chr5:17436846-17437322 | XLOC_004308 |
46 | lnc-BASP1-3 | chr5:17404534-17404840 | NONHSAT100631 |
47 | lnc-BASP1-7 | chr5:17769003-17769093 | ENSG00000249937 |
48 | lnc-BASP1-3 | chr5:17441578-17441809 | XLOC_004308 |
49 | lnc-BASP1-3 | chr5:17441578-17441803 | XLOC_004308 |
50 | lnc-MYO10-12 | chr5:17587399-17587632 | NONHSAT100653 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000251304 | TF binding region |
ENSG00000249427 | TF binding region |
ENSG00000249282 | TF binding region |
ENSG00000250558 | TF binding region |
ENSG00000250807 | TF binding region |
ENSG00000250296 | TF binding region |
ENSG00000248455 | TF binding region |
ENSG00000250055 | TF binding region |
ENSG00000249339 | TF binding region |
ENSG00000250386 | TF binding region |
ENSG00000250715 | TF binding region |
ENSG00000249329 | TF binding region |
ENSG00000249156 | TF binding region |
ENSG00000248337 | TF binding region |
ENSG00000248160 | TF binding region |
ENSG00000268799 | TF binding region |
ENSG00000249937 | TF binding region |
ENSG00000249620 | TF binding region |
ENSG00000248542 | TF binding region |
ENSG00000248861 | TF binding region |
ENSG00000248205 | TF binding region |
ENSG00000248471 | TF binding region |
ENSG00000250667 | TF binding region |
ENSG00000248422 | TF binding region |
ENSG00000269466 | TF binding region |
ENSG00000271296 | TF binding region |
ENSG00000250351 | TF binding region |
ENSG00000249666 | TF binding region |
ENSG00000249357 | TF binding region |
ENSG00000249662 | TF binding region |
ENSG00000250088 | TF binding region |
ENSG00000250782 | TF binding region |
ENSG00000185041 | TF binding region |
ENSG00000251304 | CpG island |
ENSG00000249427 | CpG island |
ENSG00000249282 | CpG island |
ENSG00000250558 | CpG island |
ENSG00000250807 | CpG island |
ENSG00000250296 | CpG island |
ENSG00000248455 | CpG island |
ENSG00000250055 | CpG island |
ENSG00000249339 | CpG island |
ENSG00000250386 | CpG island |
ENSG00000250715 | CpG island |
ENSG00000249329 | CpG island |
ENSG00000249156 | CpG island |
ENSG00000248337 | CpG island |
ENSG00000248160 | CpG island |
ENSG00000268799 | CpG island |
ENSG00000249937 | CpG island |
ENSG00000249620 | CpG island |
ENSG00000248542 | CpG island |
ENSG00000248861 | CpG island |
ENSG00000248205 | CpG island |
ENSG00000248471 | CpG island |
ENSG00000250667 | CpG island |
ENSG00000248422 | CpG island |
ENSG00000269466 | CpG island |
ENSG00000271296 | CpG island |
ENSG00000250351 | CpG island |
ENSG00000249666 | CpG island |
ENSG00000249357 | CpG island |
ENSG00000249662 | CpG island |
ENSG00000250088 | CpG island |
ENSG00000250782 | CpG island |
ENSG00000185041 | CpG island |
ENSG00000250667 | chromatin interactions |
ENSG00000250782 | chromatin interactions |
ENSG00000268799 | chromatin interactions |
ENSG00000248542 | chromatin interactions |
ENSG00000251304 | chromatin interactions |
ENSG00000215196 | chromatin interactions |
ENSG00000176788 | chromatin interactions |
ENSG00000248471 | chromatin interactions |
GTF2H1 | miRNA target sites |
RNF41 | miRNA target sites |
PRKCE | miRNA target sites |
RAE1 | miRNA target sites |
GTF2I | miRNA target sites |
RAD51 | miRNA target sites |
GXYLT1 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs867356 | chr5:17398090-17398091 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs188526509 | chr5:17398101-17398102 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs376665720 | chr5:17398163-17398164 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs904861 | chr5:17398173-17398174 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs547770448 | chr5:17398177-17398178 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568092198 | chr5:17398193-17398194 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs193163764 | chr5:17398214-17398215 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs556895905 | chr5:17398218-17398219 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs184982308 | chr5:17398238-17398239 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs11133898 | chr5:17398246-17398247 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs539664219 | chr5:17398274-17398275 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs112460341 | chr5:17398278-17398279 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs576389369 | chr5:17398353-17398354 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs535788192 | chr5:17398394-17398395 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545630080 | chr5:17398403-17398404 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs190718260 | chr5:17398425-17398426 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs560637990 | chr5:17398478-17398479 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs148120836 | chr5:17398514-17398515 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs549033857 | chr5:17398615-17398616 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs76168285 | chr5:17398696-17398697 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541126198 | chr5:17398708-17398709 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs870893 | chr5:17398728-17398729 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs373286479 | chr5:17398758-17398759 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577788876 | chr5:17398766-17398767 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs111334917 | chr5:17398773-17398774 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181816901 | chr5:17398796-17398797 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563552457 | chr5:17398802-17398803 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs141884651 | chr5:17398828-17398829 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549316255 | chr5:17398841-17398842 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs117473494 | chr5:17398860-17398861 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs573003024 | chr5:17398884-17398885 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs527320021 | chr5:17398927-17398928 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs150197611 | chr5:17398929-17398930 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs570501189 | chr5:17398934-17398935 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs183897319 | chr5:17398995-17398996 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs549961745 | chr5:17399033-17399034 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549691909 | chr5:17399075-17399076 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
38 | rs372996821 | chr5:17399097-17399098 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
39 | rs138693897 | chr5:17399117-17399118 | Enhancers Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
40 | rs555673241 | chr5:17399154-17399155 | Enhancers Weak transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs377499838 | chr5:17399156-17399157 | Enhancers Weak transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs547212301 | chr5:17399180-17399181 | Enhancers Weak transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs188277827 | chr5:17399221-17399222 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs535043707 | chr5:17399253-17399254 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs557887155 | chr5:17399310-17399311 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs375459374 | chr5:17399335-17399336 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs539707962 | chr5:17399338-17399339 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs558050248 | chr5:17399340-17399341 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs576353792 | chr5:17399341-17399342 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs529806808 | chr5:17399344-17399345 | Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 21364760 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Lung cancer | 16740712 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Melanoma | 22183965 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Prostate cancer | 21965145 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Autism | 19287141 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Schizophrenia | 23813976 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:17396400-17400000 | Weak transcription | Placenta | Placenta |
2 | chr5:17396600-17398200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr5:17396600-17400800 | Weak transcription | Fetal Kidney | kidney |
4 | chr5:17396800-17398400 | Weak transcription | GM12878-XiMat | blood |
5 | chr5:17396800-17399600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr5:17397000-17398600 | Weak transcription | Placenta Amnion | Placenta Amnion |
7 | chr5:17397200-17401600 | Enhancers | Primary B cells from peripheral blood | blood |
8 | chr5:17397400-17400800 | Weak transcription | Ovary | ovary |
9 | chr5:17397600-17402000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
10 | chr5:17397800-17399200 | Enhancers | NHLF | lung |
11 | chr5:17397800-17399400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
12 | chr5:17397800-17399400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
13 | chr5:17397800-17399400 | Enhancers | HMEC | breast |
14 | chr5:17397800-17399400 | Enhancers | Osteobl | bone |
15 | chr5:17397800-17399600 | Enhancers | NH-A | brain |
16 | chr5:17397800-17401000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr5:17397800-17403000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
18 | chr5:17398000-17398800 | Enhancers | HSMMtube | muscle |
19 | chr5:17398000-17399000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
20 | chr5:17398000-17399000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
21 | chr5:17398000-17399000 | Enhancers | Hela-S3 | cervix |
22 | chr5:17398000-17399200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
23 | chr5:17398000-17399200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
24 | chr5:17398000-17399200 | Enhancers | A549 | lung |
25 | chr5:17398000-17399600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
26 | chr5:17398000-17399600 | Enhancers | HSMM | muscle |
27 | chr5:17398000-17399600 | Enhancers | NHDF-Ad | bronchial |
28 | chr5:17398000-17399600 | Enhancers | NHEK | skin |
29 | chr5:17398000-17400200 | Enhancers | Primary hematopoietic stem cells | blood |
30 | chr5:17398000-17400800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
31 | chr5:17398000-17400800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
32 | chr5:17398200-17398400 | Enhancers | H9 Cell Line | embryonic stem cell |
33 | chr5:17398200-17398400 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
34 | chr5:17398200-17399000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
35 | chr5:17398200-17399000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
36 | chr5:17398200-17399200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
37 | chr5:17398200-17399200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
38 | chr5:17398200-17399200 | Enhancers | Muscle Satellite Cultured Cells | -- |
39 | chr5:17398200-17399400 | Enhancers | H1 Cell Line | embryonic stem cell |
40 | chr5:17398200-17399600 | Bivalent Enhancer | iPS-20b Cell Line | embryonic stem cell |
41 | chr5:17398200-17400600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
42 | chr5:17398200-17400800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
43 | chr5:17398400-17399200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
44 | chr5:17398400-17399600 | Enhancers | GM12878-XiMat | blood |
45 | chr5:17398400-17400600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
46 | chr5:17398600-17399000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
47 | chr5:17398600-17399200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
48 | chr5:17398600-17399200 | Enhancers | Placenta Amnion | Placenta Amnion |
49 | chr5:17398600-17399200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
50 | chr5:17398600-17403000 | Enhancers | Primary monocytes fromperipheralblood | blood |